Cue Biopharma, Inc.CUENASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank70
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-21.69M
↑ 24% vs avg
Percentile
P70
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-28.65M
Historical baseline
PeriodValueYoY Change
2025$-21.69M+40.3%
2024$-36.33M+9.1%
2023$-39.96M+4.4%
2022$-41.81M-7.6%
2021$-38.84M-19.5%
2020$-32.49M-5.5%
2019$-30.80M-16.6%
2018$-26.41M-116.6%
2017$-12.19M-104.3%
2016$-5.97M-